ArticleNature communications2026
Multimodal deep learning model for AI-based functional prognostic risk stratification in patients undergoing radical nephrectomy.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
43 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Making the decision between technically challenging partial nephrectomy (PN) and radical nephrectomy (RN) in patients with complex renal cell carcinoma (RCC) remains a significant challenge for urologists. Rapid glomerular filtration rate (GFR) decline (annual decline >3 mL/min/1.73 m²) after RN is considered an abnormal renal function state, and if this risk can be predicted preoperatively, PN may be pursued even when technically demanding. We retrospectively analyze contrast-enhanced computed tomography images and clinical data from 1621 patients across multiple centers. A multimodal deep learning model is developed to predict rapid GFR decline after RN. The model achieves an area under the curve of 0.788-0.873 in external test sets. It stratifies patients into high- and low-risk groups with significantly different risks of chronic kidney disease progression. Here we show that the model demonstrates potential for assisting treatment decisions in patients with complex RCC for whom PN is challenging but feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.